Vivos Therapeutics Insiders Bulk Buy 1.045 Million Shares at $1.34—A Bullish Bet Amid Volatility
Insider buying spree shows Vivos Therapeutics’ confidence amid 48% YTD drop, hinting at a potential rebound as management backs future upside.
3 minutes to read